FBXW7 and chronic myelogenous leukemia, BCR-ABL1 positive: For instances, FBXW7 deletion induced T-cell acute lymphoblastic leukemia (T-ALL) development without the requirement of other tumor-promoting factors [11], while it eliminated LSCs of chronic myeloid leukemia (CML) by preventing quiescence [12].